Ibersol, S.G.P.S. stock: fair value
IBS.LSThe fair value of Ibersol, S.G.P.S. under our model is $34.74, the price is 66% below.
The fair value is an estimate from our model, not a price target.
Daily figure as of 13 Nov 2026
Valuation signal
Significantly undervaluedIn our model the price counts as cheap below $24.82 and expensive above $57.91 (uncertainty high, one part of the fair value is more than twice the other).
The two parts of the fair value come to $60.07 (cash-flow model) and $9.42 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 10.6%. At 11.6% the fair value would be $31.11, at 9.6% it would be $39.47.
Where the number comes from
Half from the cash-flow model, half from earnings times the industry P/E (25).
Ten-year cash-flow model from smoothed free cash flow and its past growth until it reaches 2.8%. Discounted at 10.6% (government bond yield 2.8% plus beta 1.35 times a risk premium of 5.8%); no analyst estimates were available.
Calculate with your own assumptionsThe calculation step by step
With these figures the cash flow model arrives at $60.07 per share: free cash flow for the next ten years, each year discounted to today at 10.6%, plus the terminal value for the years after. The table explains the calculation; it is not a recommendation.
Calculation as a table
| Year | Free cash flow | Source | Discount factor | Present value (discounted at 10.6%) |
|---|---|---|---|---|
| 2026 | $125.75M | extrapolated at 25.6% | 0.9040 | $113.68M |
| 2027 | $149.38M | extrapolated at 18.8% | 0.8172 | $122.07M |
| 2028 | $170.3M | extrapolated at 14.0% | 0.7387 | $125.8M |
| 2029 | $188.43M | extrapolated at 10.7% | 0.6678 | $125.83M |
| 2030 | $204.06M | extrapolated at 8.3% | 0.6037 | $123.18M |
| 2031 | $217.64M | extrapolated at 6.7% | 0.5457 | $118.77M |
| 2032 | $229.62M | extrapolated at 5.5% | 0.4933 | $113.27M |
| 2033 | $240.41M | extrapolated at 4.7% | 0.4459 | $107.21M |
| 2034 | $250.36M | extrapolated at 4.1% | 0.4031 | $100.92M |
| 2035 | $259.72M | extrapolated at 3.7% | 0.3644 | $94.64M |
| Step | Value |
|---|---|
| Sum of present values (ten years) | $1.15B |
| Terminal value: cash flow 2035 × (1 + 2.8%) / (10.6% − 2.8%) | $3.42B |
| Present value of terminal value (× 0.3644) | $1.25B |
| Equity value (sum plus present value of terminal value) | $2.39B |
| Shares (diluted) | 39.83M |
| Value per share (equity value divided by shares) | $60.07 |
| Earnings per share, last twelve months | $0.38 |
| × 25 (industry P/E) | $9.42 |
| Fair value (average of both parts) | $34.74 |
The model uses free cash flow after interest, which belongs to shareholders, discounted at the cost of equity. Net debt is therefore not deducted again.
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 17 Oct 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.